LivaNova (NASDAQ:LIVN) Upgraded at StockNews.com

StockNews.com upgraded shares of LivaNova (NASDAQ:LIVN) from a buy rating to a strong-buy rating in a research report report published on Tuesday.

A number of other analysts have also weighed in on LIVN. Stifel Nicolaus dropped their target price on shares of LivaNova from $72.00 to $60.00 and set a “buy” rating for the company in a report on Wednesday, February 26th. Wolfe Research cut LivaNova from an “outperform” rating to a “peer perform” rating in a report on Wednesday, February 26th. Barclays reduced their target price on LivaNova from $58.00 to $56.00 and set an “equal weight” rating on the stock in a research note on Friday, March 7th. The Goldman Sachs Group dropped their price target on LivaNova from $64.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Finally, Needham & Company LLC reissued a “buy” rating and set a $64.00 price objective on shares of LivaNova in a research report on Monday, March 17th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, LivaNova presently has an average rating of “Buy” and an average target price of $61.17.

LivaNova Stock Performance

LivaNova stock opened at $39.62 on Tuesday. The firm has a fifty day simple moving average of $44.69 and a two-hundred day simple moving average of $48.52. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. LivaNova has a twelve month low of $36.85 and a twelve month high of $64.48. The company has a market capitalization of $2.15 billion, a PE ratio of 94.33 and a beta of 1.10.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LIVN. Russell Investments Group Ltd. raised its stake in LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock valued at $70,000 after buying an additional 219 shares during the last quarter. Sterling Capital Management LLC increased its position in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock valued at $75,000 after acquiring an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division lifted its holdings in LivaNova by 21.2% in the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock valued at $191,000 after acquiring an additional 720 shares during the period. Vestcor Inc bought a new position in LivaNova in the fourth quarter valued at about $204,000. Finally, Optimize Financial Inc purchased a new position in LivaNova in the fourth quarter worth about $208,000. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.